Значения термина malignant biliary на английском

Patients and methods: Eight patients with inoperable malignant biliary and duodenal strictures were enrolled.

We report our experience, in a retrospective review, of 505 patients with malignant biliary obstruction.

Distinguishing benign from malignant biliary strictures with routine biliary cytology in this population is challenging.

We analyzed 29 patients in whom bile duct stenting was performed for malignant biliary obstruction.

This paper gives an overview of experience and success of percutaneous transhepatic interventions in malignant biliary obstruction.

Conclusions: Endobiliary sampling is technically difficult and has a limited sensitivity for the diagnosis of malignant biliary stenosis.

Combined endoscopic biliary and duodenal stent-in-stent placement is a promising solution for the palliation of malignant biliary and duodenal obstruction.

It achieves biliary drainage with an acceptable risk to benefit ratio in the majority of patients with distal malignant biliary obstruction.

The role of ERCP and endoscopic drainage in the diagnosis and treatment of patients with malignant biliary obstruction is well established.

Conclusion: Combined biliary and duodenal stenting seems to be safe and effective in palliation of inoperable malignant biliary and duodenal obstruction.

Non-surgical methods to treat patients with inoperable malignant biliary obstruction are endoscopic retrograde biliary drainage and ultrasound guided percutaneous transhepatic biliary drainage.

This paper aims to study the clinical utility of fluorescence in situ hybridization (FISH) in enhancing identification of malignant biliary strictures.

Hilar cholangiocarcinoma is an uncommon cause of malignant biliary obstruction marked by local tumor spread for which surgery offers the only chance of cure.

A total of 83 self-expandable metallic stents were placed percutaneously in 69 patients for palliation of malignant biliary obstruction.

These findings indicate that, while a positive cytologic diagnosis is a reliable indicator of a malignant biliary obstruction, a negative result does not exclude malignancy.

Background: This study evaluated the efficacy and the complications associated with the use of the covered Wallstent in the setting of unresectable malignant biliary obstruction.